FDA May Seek Industry's Blanket Consent For Trade Secret Info Release
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking alternatives to the current practice of obtaining industry consent on a case-by-case basis to share confidential commercial information and trade secrets with foreign governments, FDA Associate Director for International Agreements Merton Smith said at a Dec. 8 public meeting.